Bullish
RedHill Biopharma closes $6 million private placement
RedHill Biopharma Ltd. announced the closing of a $6 million private placement through the sale of American Depositary Shares and warrants. The procee...
Bullish
RedHill Biopharma Ltd. announced the closing of a $6 million private placement through the sale of American Depositary Shares and warrants. The procee...
Bullish
RedHill Biopharma is actively pursuing collaborations to advance its investigational oral drug, opaganib, for the treatment of Ebola Virus Disease (EV...